Flare treatment Apply to affected area once daily for 4 wk. Max daily dose: 15 g. (2-sec application delivers approx 0.5 g which covers skin area roughly corresponding to surface area of adult hand.) Long-term maintenance treatment Apply twice wkly on 2 non-consecutive days to previously affected areas w/ 2-3 days interval. Flare treatment should be re-initiated if signs of relapse occur.
Discontinue use if infection worsens or hypercalcaemia occurs. Adrenocortical suppression or impaired glycaemic control of DM; visual disturbances eg, cataract, glaucoma or central serous chorioretinopathy; risk of rebound effects upon discontinuation; guttate psoriasis. Avoid application under occlusive dressings, on large areas of damaged skin, mucous membranes or skin folds; contact w/ face, mouth & eyes. Not to be used in facial & genital skin. Long-term use. Avoid abrupt w/drawal. Avoid concurrent treatment w/ other steroids. May cause local skin reactions or irritation due to butylhydroxytoluene. Severe renal & hepatic impairment. Pregnancy. Not to be used during lactation. Childn <18 yr.
Sign Out
